Dysplasien und Carcinomata in situ des Larynx

U. Schroeder; M. P.E. Gebhard; B. Wollenberg

doi:10.1007/s00106-011-2424-7

Dysplasien und Carcinomata in situ des Larynx

Translated title of the contribution: Dysplasia and laryngeal carcinoma in situ

U. Schroeder, M. P.E. Gebhard, B. Wollenberg

Universitätsklinikum Schleswig-Holstein Campus Lübeck

Research output: Contribution to journal › Article › peer-review

2 Scopus citations

Abstract

Although the glottis is amenable to chemotherapy, currently most lesions from stage I laryngeal dysplasia up to carcinoma in situ are excised. This literature review presents selected molecular biological aspects especially in relation to dysplasia of the larynx and its therapy, as well as currently preferred biomarkers for chemotherapeutic prevention of laryngeal dysplasia.

Translated title of the contribution	Dysplasia and laryngeal carcinoma in situ
Original language	German
Pages (from-to)	41-43
Number of pages	3
Journal	HNO
Volume	60
Issue number	1
DOIs	https://doi.org/10.1007/s00106-011-2424-7
State	Published - Jan 2012
Externally published	Yes

Access to Document

10.1007/s00106-011-2424-7

Cite this

@article{0900d55103e44ec8ada74052b9a8db76,

title = "Dysplasien und Carcinomata in situ des Larynx",

abstract = "Although the glottis is amenable to chemotherapy, currently most lesions from stage I laryngeal dysplasia up to carcinoma in situ are excised. This literature review presents selected molecular biological aspects especially in relation to dysplasia of the larynx and its therapy, as well as currently preferred biomarkers for chemotherapeutic prevention of laryngeal dysplasia.",

keywords = "Biomarkers, Chemoprevention, Hoarseness, Laryngeal cancer, Precancerous conditions",

author = "U. Schroeder and Gebhard, {M. P.E.} and B. Wollenberg",

year = "2012",

month = jan,

doi = "10.1007/s00106-011-2424-7",

language = "Deutsch",

volume = "60",

pages = "41--43",

journal = "HNO",

issn = "0017-6192",

publisher = "Springer Verlag",

number = "1",

}

TY - JOUR

T1 - Dysplasien und Carcinomata in situ des Larynx

AU - Schroeder, U.

AU - Gebhard, M. P.E.

AU - Wollenberg, B.

PY - 2012/1

Y1 - 2012/1

N2 - Although the glottis is amenable to chemotherapy, currently most lesions from stage I laryngeal dysplasia up to carcinoma in situ are excised. This literature review presents selected molecular biological aspects especially in relation to dysplasia of the larynx and its therapy, as well as currently preferred biomarkers for chemotherapeutic prevention of laryngeal dysplasia.

AB - Although the glottis is amenable to chemotherapy, currently most lesions from stage I laryngeal dysplasia up to carcinoma in situ are excised. This literature review presents selected molecular biological aspects especially in relation to dysplasia of the larynx and its therapy, as well as currently preferred biomarkers for chemotherapeutic prevention of laryngeal dysplasia.

KW - Biomarkers

KW - Chemoprevention

KW - Hoarseness

KW - Laryngeal cancer

KW - Precancerous conditions

UR - http://www.scopus.com/inward/record.url?scp=84856317516&partnerID=8YFLogxK

U2 - 10.1007/s00106-011-2424-7

DO - 10.1007/s00106-011-2424-7

M3 - Artikel

C2 - 22282009

AN - SCOPUS:84856317516

SN - 0017-6192

VL - 60

SP - 41

EP - 43

JO - HNO

JF - HNO

IS - 1

ER -

Dysplasien und Carcinomata in situ des Larynx

Abstract

Access to Document

Other files and links

Fingerprint

Cite this